Repligen Corporation
RGENNASDAQHealthcare● Active
$125.33
+$3.02(+2.47%)
Market Cap$7.1B
P/E Ratio—
52W High$175.77
52W Low$100.99
Repligen Corporation (RGEN) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · RGEN · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.05B | ($0.03B) | $0.04B | $0.19B | $0.13B |
| Depreciation & Amort. | $0.10B | $0.09B | $0.07B | $0.06B | $0.04B |
| Stock-Based Comp. | $0.03B | $0.05B | $0.03B | $0.03B | $0.03B |
| Change in Working Capital | ($0.05B) | $0.06B | ($0.01B) | ($0.07B) | ($0.10B) |
| Net Cash from Operations | $0.12B | $0.18B | $0.11B | $0.17B | $0.12B |
| Investing Activities | |||||
| Capital Expenditure | ($0.02B) | ($0.03B) | ($0.04B) | ($0.13B) | ($0.07B) |
| Purchases of Investments | ($0.20B) | $0.00B | $0.00B | ($0.10B) | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.10B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.30B) | ($0.09B) | ($0.12B) | ($0.23B) | ($0.22B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | ($0.01B) | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | ($0.07B) | $0.29B | $0.00B | ($0.00B) |
| Net Cash from Financing | ($0.02B) | ($0.08B) | $0.25B | ($0.01B) | $0.00B |
| Free Cash Flow | |||||
| Free Cash Flow | $0.09B | $0.14B | $0.07B | $0.04B | $0.05B |
| FCF Margin %(computed) | 12.72% | 22.46% | 11.85% | 4.83% | 7.12% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Repligen Corporation data
About Repligen Corporation (RGEN) Cash Flow Statement
Repligen Corporation generated operating cash flow of $0.12B and free cash flow of $0.09B for 2025 — a FCF margin of 12.72%. Capital expenditure was ($0.02B).
Frequently asked questions
RGEN · 4 questionsRepligen Corporation generated free cash flow of $0.09B for 2025, down 34.1% year-over-year.
RGEN free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10